ScreenerHero

0QAV Nanobiotix S.A.

LSE · GB · Healthcare · Biotechnology · nanobiotix.com
22.44EUR+1.17%Mkt Cap: —P/E: —

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value1.23B USD
Revenue (TTM)12.51M USD
Gross Profit12.51M USD
Net Income (TTM)-57.46M USD
Revenue/Share0.24 EUR
Last Price22.44 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees100
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-38.13
EV/Revenue98.71
P/S—
P/B-34.16
EPS (TTM)-1.35
EPS (Forward)—
52W Range
7.16038% of range47.60
52W High47.60 EUR
52W Low7.160 EUR
Profitability
Gross Margin100.00%
Oper. Margin-322.88%
EBITDA Margin-258.87%
Profit Margin0.00%
ROE—
ROA-21.34%
Growth
Revenue Growth-79.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-37.16M USD
CapEx (TTM)—
FCF Margin-284.91%
FCF Yield—
Net Debt-4.65M USD
Net Debt/EBITDA0.14
Balance Sheet
Debt/Equity—
Current Ratio1.44
Quick Ratio1.40
Book Value/Sh-0.66 EUR
Cash/Share2.18 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.19.61M
Float35.15M
Insiders15.55%
Institutions29.43%
Technical
SMA 506.677 (+236.1%)
SMA 2006.545 (+242.9%)
Beta0.59
S&P 52W Chg15.78%
Avg Vol (30d)11.75K
Avg Vol (10d)1.94K
Technical Indicators
RSI (14)26.9
MACD-2.5691
MACD Signal-1.8342
MACD Hist.-0.7349
BB Upper34.69 EUR
BB Middle28.56 EUR
BB Lower22.43 EUR
BB Width42.93%
ATR (14)2.019 EUR
Vol Ratio (20d)3.38x